FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Heparin Sodium and Sodium Chloride 0.9% Injection
Status: Currently in Shortage
»Date first posted: 11/14/2017
»Therapeutic Categories: Hematology

Expand all

Baxter Healthcare (Reverified 09/08/2020)

Company Contact Information:
888-229-0001

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
Heparin Sodium BP 2,000 IU/L in 0.9% w/v Sodium Chloride IV Infusion in VIAFLEX container (1,000 units / 500 mL) Product code FKB0953G (NDC 0338-9556-20) Unavailable Baxter Healthcare Corporation in conjunction with FDA has initiated temporary importation of Heparin IV Infusion into the U.S. market to address drug shortages.

Dear Health Care Letter, United Kingdom

Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 2,000 USP units in 1000 mL. Product code 2B0944 (NDC 0338-0433-04) Available
Heparin Sodium and 0.9% Sodium Chloride Injection in VIAFLEX Plus Plastic Container: 1,000 USP units in 500 mL. Product code 2B0953 (NDC 0338-0431-03) Unavailable Product code 2B0953 was replaced with code AHB0953U Other
Heparin Sodium and 0.9% Sodium Chloride Injection, 1,000 units / 500 mL (2 units / mL) in VIAFLEX Plastic Container. Product code AHB0953U (NDC 0338-0424-18) Available Product code AHB0953U replaces code 2B0953

Fresenius Kabi USA, LLC (New 08/04/2020)

Company Contact Information:
888-386-1300

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1,000 Units/500 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-77) Expected availability February 2021 Other
2,000 Units/1000 mL; (2 units/mL); Single dose, freeflex bag; (NDC 63323-519-10) Expected availability February 2021 Other

Hospira, Inc. (Revised 09/10/2020)

Company Contact Information:
844-646-4398

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1,000 Units/500 mL (2 Units/mL); Flexible Container (NDC 00409-7620-03) Limited Supply Available. Next Delivery: September 2020; Estimated Recovery: October 2020 Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay Other
2,000 Units/1000 mL (2 Units/mL); Flexible Container (NDC 00409-7620-59) Limited Supply Available. Next Delivery and Estimated Recovery: September 2020 Demand increase for the drug

Sagent Pharmaceuticals (Reverified 09/11/2020)

Company Contact Information:
866-625-1618

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1000 units/mL 10mL pack 25 (NDC 25021-400-10) Available.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English